.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: RE38919

« Back to Dashboard

Claims for Patent: RE38919

Title: Injectable microfoam containing a sclerosing agent
Abstract:Injectable microfoam for sclerotcraphy. The sclerotherapy of varices is based on the injection of liquid substances capable of suppressing them. The present invention relates to the preparation of sclerosing substances in the form of a microfoam. The microfoam is prepared with sclerosing agents, and is then injected in the vein to be treated, so that the microfoam displaces the blood contained in the vein and provides for the contact of the sclerosing agent with the vascular endothelium, with a predetermined known concentration and during a controllable time.
Inventor(s): Garrido; Juan Cabrera (Granada, ES), Garcia-Olmedo; Juan Cabrera (Granada, ES)
Assignee: BTG International Limited (London, GB)
Application Number:10/458,806
Patent Claims: 1. Prepared or extemporaneously prepared injectable microfoam for therapeutic uses characterized in that the microfoam is prepared with any sclerosing substance..]..[.

2. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance is polydocanol..]..[.

3. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance is sodium tetradecyl sulfate..]..[.

4. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance is a hypertonic glucostated by glucosaline solution..]..[.

5. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance used is chromated glycerol..]..[.

6. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance used is ethanolamine oleate..]..[.

7. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance used is sodium morrhuate..]..[.

8. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance used is any iodated solution..]..[.

9. A method for phlebologic treatment comprising injecting the microfoam of claim 1 into vessels to be treated..]..[.

10. A method for phlebologic treatment comprising injecting the microfoam of claim 2 into vessels to be treated..]..[.

11. A method for phlebologic treatment comprising injecting the microfoam of claim 3 into vessels to be treated..]..[.

12. A method for treatment of esophageal varices comprising injecting the microfoam of claim 1 into vessels to be treated..]..[.

13. A method for treatment of esophageal varices comprising injecting the microfoam of claim 2 into vessels to be treated..]..[.

14. A method for treatment of esophageal varices comprising injecting the microfoam of claim 3 into vessels to be treated..]..[.

15. A method for proctologic treatment comprising injecting the microfoam of claim 1 into vessels to be treated..]..[.

16. A method for proctologic treatment comprising injecting the microfoam of claim 2 into vessels to be treated..]..[.

17. A method for proctologic treatment comprising injecting the microfoam of claim 3 into vessels to be treated..]..[.

18. A method for angiologic treatment comprising injecting the microfoam of claim 1 into vessels to be treated..]..[.

19. A method for angiologic treatment comprising injecting the microfoam of claim 2 into vessels to be treated..]..[.

20. A method for angiologic treatment comprising injecting the microfoam of claim 3 into vessels to be treated..]..Iadd.

21. An injectable microfoam for therapeutic use that is prepared or extemporaneously prepared comprising at least one sclerosing substance chosen from polidocanol, sodium tetradecyl sulfate, hypertonic glucosated solutions, hypertonic glucosaline solutions, chromated glycerol, ethanolamine oleate, sodium morrhuate, and iodated solutions, and wherein the injectable microfoam is made in a container under pressure of oxygen..Iaddend..Iadd.

22. The injectable microfoam of claim 21, wherein the at least one sclerosing substance is polidocanol..Iaddend..Iadd.

23. The injectable microfoam of claim 21, wherein the microfoam further comprises at least one substance with a foaming capacity..Iaddend..Iadd.

24. The injectable microfoam of claim 23, wherein the at least one substance with a foaming capacity is chosen from polysorbate 20, polysorbate 80, and polygeline..Iaddend..Iadd.

25. An injectable microfoam for therapeutic use that is prepared or extemporaneously prepared comprising at least one sclerosing substance chosen from polidocanol, sodium tetradecyl sulfate, hypertonic glucosated solutions, hypertonic glucosaline solutions, chromated glycerol, ethanolamine oleate, sodium morrhuate, and iodated solutions, and wherein the injectable microfoam is made in a container under pressure of a mixture of oxygen and carbon dioxide..Iaddend..Iadd.

26. The injectable microfoam of claim 25, wherein the at least one sclerosing substance is polidocanol..Iaddend..Iadd.

27. The injectable microfoam of claim 25, wherein the microfoam further comprises at least one substance with a foaming capacity..Iaddend..Iadd.

28. The injectable microfoam of claim 27, wherein the at least one substance with a foaming capacity is chosen from polysorbate 20, polysorbate 80, and polygeline..Iaddend..Iadd.

29. An injectable microfoam for therapeutic use that is prepared or extemporaneously prepared comprising at least one sclerosing substance chosen from polidocanol, sodium tetradecyl sulfate, hypertonic glucosated solutions, hypertonic glucosaline solutions, chromated glycerol, ethanolamine oleate, sodium morrhuate, and iodated solutions, and wherein the injectable microfoam is made under pressure of oxygen in a hermetic container..Iaddend..Iadd.

30. The injectable microfoam of claim 29, wherein the at least one sclerosing substance is polidocanol..Iaddend..Iadd.

31. The injectable microfoam of claim 29, wherein the microfoam further comprises at least one substance with a foaming capacity..Iaddend..Iadd.

32. The injectable microfoam of claim 31, wherein the at least one substance with a foaming capacity is chosen from polysorbate 20, polysorbate 80, and polygeline..Iaddend..Iadd.

33. An injectable microfoam for therapeutic use that is prepared or extemporaneously prepared comprising at least one sclerosing substance chosen from polidocanol, sodium tetradecyl sulfate, hypertonic glucosated solutions, hypertonic glucosaline solutions, chromated glycerol, ethanolamine oleate, sodium morrhuate, and iodated solutions, and wherein the injectable microfoam is made under pressure of a mixture of oxygen and carbon dioxide in a hermetic container..Iaddend..Iadd.

34. The injectable microfoam of claim 33, wherein the at least one sclerosing substance is polidocanol..Iaddend..Iadd.

35. The injectable microfoam of claim 33, wherein the microfoam further comprises at least one substance with a foaming capacity..Iaddend..Iadd.

36. The injectable microfoam of claim 35, wherein the at least one substance with a foaming capacity is chosen from polysorbate 20, polysorbate 80, and polygeline..Iaddend.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc